(Circulation. 2008;117:832-840.)
© 2008 American Heart Association, Inc.
Basic Science for Clinicians |
From the Departments of Internal Medicine (Section of Cardiovascular Medicine) and Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Conn.
Correspondence to Lawrence H. Young, MD, 333 Cedar St, New Haven, CT 06520. E-mail lawrence.young@yale.edu
Key Words: AMP kinase fatty acids glucose ischemia signal transduction
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
The present article will focus on the AMP-activated protein kinase (AMPK), a molecular stress response pathway that is activated by increases in the intracellular concentration of AMP. AMP is not to be confused with cAMP, a molecular signal produced during stress by catecholamine-induced β-adrenergic stimulation. The AMPK pathway has received a great deal of attention because of its potential importance in the ischemic heart,1,2 diabetes,3 and cancer.4 Several recent reviews have summarized scientific discoveries related to AMPK and can provide the interested reader with additional insights into the field.2,5–7 The present article will strive to provide a perspective that is accessible to the clinician with an interest in contemporary basic science research. It is hoped that the reader will develop an understanding of how AMPK functions in the heart to orchestrate the cellular response to ischemic stress.
| AMP and Cellular Energy Stress |
|---|
This article has been cited by other articles:
![]() |
R. R. Lamberts, G. Onderwater, N. Hamdani, M. J. A. Vreden, J. Steenhuisen, E. C. Eringa, S. A. Loer, G. J.M. Stienen, and R. A. Bouwman Reactive Oxygen Species-Induced Stimulation of 5'AMP-Activated Protein Kinase Mediates Sevoflurane-Induced Cardioprotection Circulation, September 15, 2009; 120(11_suppl_1): S10 - S15. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, L. Tao, Y. Yuan, W. B. Lau, R. Li, B. L. Lopez, T. A. Christopher, R. Tian, and X.-L. Ma Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E384 - E391. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, E. Gao, L. Tao, W. B. Lau, Y. Yuan, B. J. Goldstein, B. L. Lopez, T. A. Christopher, R. Tian, W. Koch, et al. AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin Circulation, February 17, 2009; 119(6): 835 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. G. Edwards, M. Y. White, and S. J. Cordwell The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery Mol. Cell. Proteomics, October 1, 2008; 7(10): 1824 - 1837. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |